RAPP
Rapport Therapeutics, Inc. · Healthcare
Chief Executive Officer Abraham Ceesay sold $87K of Rapport Therapeutics, Inc.
Sold$86,565
$39.17Price
2,210Shares
0%Stake
What RAPP did after the filing
- The stock from Fri, Sep 25 open, $33.80
- −23.3%
- S&P 500, same days
- −1.1%
20 of 30 trading days so far, to the Oct 23 close.
Traded Wed, Sep 23. Filed Thu, Sep 24, 4:05 PM ET, after the close. Returns use the Sep 25 open and the Oct 23 close. Not investment advice.